Pituitary Axis Impacts and Effectiveness of Clomiphene and Human Chorionic Gonadotropin in Treating Hypogonadism: Cohort Study
Year: 2026
Type: article
Study design: Observational Study
Abstract: PURPOSE: Men with testosterone deficiency (TD) aiming to preserve testicular function can be treated with strategies including testosterone replacement therapy (TRT) combined with human chorionic gonadotropin (hCG) or clomiphene citrate (CC), or CC monotherapy. Evidence regarding these strategies on the pituitary axis and quality of life is limited. MATERIALS AND METHODS: This retrospective cohort study compared the effects of hCG+TRT, CC+TRT, and CC monotherapy on pituitary axis function, testosterone levels and quality of life during TD treatment. Changes in serum luteinising hormone (LH), follicle-stimulating hormone (FSH), total and free testosterone, and quality of life (QADAM scores) from baseline to 6 months were calculated using mixed models. RESULTS: 6,999 adult men were included: 6,364 men (91%) prescribed hCG+TRT, 552 (8%) prescribed CC+TRT, 83 (1%) prescribed CC monotherapy. hCG+TRT suppressed LH and FSH (p<0.05), whereas CC+TRT was associated with reduction in FSH only (p=0.02). At 6 months, CC monotherapy was associated with significant increases in LH and FSH (p<0.001). All treatments were associated with substantial increases in total and free testosterone with rapid attainment of physiological levels (ranging from 23.58 nmol/L to 26.52 nmol/L). Similar changes in QADAM scores were observed across the three approaches (from 7.86 points to 9.50 points, all p<0.001). CONCLUSIONS: This study revealed distinct patterns in the natural history of pituitary hormone levels across different fertility-sparing strategies for TD, while observing comparable benefits in testosterone levels and quality of life. Future studies should prospectively correlate longitudinal trends in pituitary hormones with semen parameters and other fertility outcomes to enable personalised treatment selection.
DOI: 10.5534/wjmh.250422
Institutions: Menwell Limited, Imperial College London, University of Bristol
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7167415443
